NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/18/2023
Back to search
Official data from USPTO
DETERMA RX IO TX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/18/2023
Trademark type
Combined
Nice classes
10
Filing date
02/11/2022
Registration date
07/18/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/18/2023
Last transaction
07/18/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2021-12-00
First use in commerce
2021-12-00
Drawing code
3
Owner type
03
Owner location
Irvine, CA
Examiner
YAO, GRETTA
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the block letter wording DETERMA in blue, stacked over three leaf shape designs being squares having rounded corners at the top left and bottom right of each, and wherein the first is green with the letters "Rx" appearing in white in the center, the second is blue with the letters "IO" appearing in white in the center, and the third is red with the letters "Tx" appearing in white in the center.
Holders and representatives
Holders
O. C. (pessoa física)
Representatives
Christopher D. Olszyk, Jr. FOX ROTHSCHILD LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Biopsy tests and devicesmedical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; Biopsy tests and devicesmedical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Cancer screening tests and devicesmedical devices for detecting risk factors and probability of cancer reoccurrence; Cancer screening tests and devicesmedical devices for evaluating immunotherapy cancer treatment options; Cancer screening tests and devicesmedical devices for matching cancer diagnosis with cancer treatments; Medical testing device for diagnosing cancer and detecting biological traits that effect the risk of reoccurrence; Medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient; Blood testing apparatus for cancer diagnosis and evaluation of treatment options; Medical testing devices for tumor diagnosis and treatment evaluation
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/18/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/02/2023
PUBO
PUBLISHED FOR OPPOSITION
05/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/30/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/30/2022
GNRT
NON-FINAL ACTION E-MAILED
12/30/2022
CNRT
NON-FINAL ACTION WRITTEN
12/30/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/06/2022
GNRT
NON-FINAL ACTION E-MAILED
07/06/2022
CNRT
NON-FINAL ACTION WRITTEN
07/06/2022
DOCK
ASSIGNED TO EXAMINER
06/28/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/16/2022
NWAP
NEW APPLICATION ENTERED
02/15/2022
Continuous trademark protection
Get notified about every new filing that threatens DETERMA RX IO TX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.